Cargando…

Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning

Although uncommon, ovarian cancer cells may spread to the rectal lymph nodes. However, few reports have described how to detect and treat such metastases. We report a case of a 59-year-old woman with mesorectal and pararectal lymph node metastases in recurrent ovarian carcinoma, detected conclusivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumagai, Koji, Okamura, Terue, Toyoda, Masao, Senzaki, Hideto, Watanabe, Chihiro, Ohmichi, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751651/
https://www.ncbi.nlm.nih.gov/pubmed/23938043
http://dx.doi.org/10.1186/1477-7819-11-184
Descripción
Sumario:Although uncommon, ovarian cancer cells may spread to the rectal lymph nodes. However, few reports have described how to detect and treat such metastases. We report a case of a 59-year-old woman with mesorectal and pararectal lymph node metastases in recurrent ovarian carcinoma, detected conclusively using (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT), and treated by low anterior resection with total mesorectal excision aiming for macroscopic complete resection. The treatment goals for the patient were gradually changed from curative to palliative chemotherapy; she survived for 45 months without rectal obstruction after secondary debulking surgery, and was followed up until autopsy. Thus, (18)F-FDG PET/CT may be valuable for detecting rectal lymph node metastasis and can play an essential role in planning treatment for recurrent ovarian carcinoma.